These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

497 related items for PubMed ID: 30224067

  • 1. Effect of growth differentiation factor-15 secreted by human umbilical cord blood-derived mesenchymal stem cells on amyloid beta levels in in vitro and in vivo models of Alzheimer's disease.
    Kim DH, Lee D, Lim H, Choi SJ, Oh W, Yang YS, Chang JH, Jeon HB.
    Biochem Biophys Res Commun; 2018 Oct 12; 504(4):933-940. PubMed ID: 30224067
    [Abstract] [Full Text] [Related]

  • 2. GDF-15 secreted from human umbilical cord blood mesenchymal stem cells delivered through the cerebrospinal fluid promotes hippocampal neurogenesis and synaptic activity in an Alzheimer's disease model.
    Kim DH, Lee D, Chang EH, Kim JH, Hwang JW, Kim JY, Kyung JW, Kim SH, Oh JS, Shim SM, Na DL, Oh W, Chang JW.
    Stem Cells Dev; 2015 Oct 15; 24(20):2378-90. PubMed ID: 26154268
    [Abstract] [Full Text] [Related]

  • 3. Thrombospondin-1 secreted by human umbilical cord blood-derived mesenchymal stem cells rescues neurons from synaptic dysfunction in Alzheimer's disease model.
    Kim DH, Lim H, Lee D, Choi SJ, Oh W, Yang YS, Oh JS, Hwang HH, Jeon HB.
    Sci Rep; 2018 Jan 10; 8(1):354. PubMed ID: 29321508
    [Abstract] [Full Text] [Related]

  • 4. Soluble intracellular adhesion molecule-1 secreted by human umbilical cord blood-derived mesenchymal stem cell reduces amyloid-β plaques.
    Kim JY, Kim DH, Kim JH, Lee D, Jeon HB, Kwon SJ, Kim SM, Yoo YJ, Lee EH, Choi SJ, Seo SW, Lee JI, Na DL, Yang YS, Oh W, Chang JW.
    Cell Death Differ; 2012 Apr 10; 19(4):680-91. PubMed ID: 22015609
    [Abstract] [Full Text] [Related]

  • 5. Umbilical Cord Mesenchymal Stem Cells Conditioned Medium Promotes Aβ25-35 phagocytosis by Modulating Autophagy and Aβ-Degrading Enzymes in BV2 Cells.
    Xu Z, Nan W, Zhang X, Sun Y, Yang J, Lu K, Liu Y, Gao Y, Yang F, Mao W, Xing X, Du J, Li H, Li Y, Feng H, Yuan Z, Lin J.
    J Mol Neurosci; 2018 Jun 10; 65(2):222-233. PubMed ID: 29845511
    [Abstract] [Full Text] [Related]

  • 6. The therapeutic potential of human umbilical cord blood-derived mesenchymal stem cells in Alzheimer's disease.
    Lee HJ, Lee JK, Lee H, Shin JW, Carter JE, Sakamoto T, Jin HK, Bae JS.
    Neurosci Lett; 2010 Aug 30; 481(1):30-5. PubMed ID: 20600610
    [Abstract] [Full Text] [Related]

  • 7. Cooperative therapeutic action of retinoic acid receptor and retinoid x receptor agonists in a mouse model of Alzheimer's disease.
    Kawahara K, Suenobu M, Ohtsuka H, Kuniyasu A, Sugimoto Y, Nakagomi M, Fukasawa H, Shudo K, Nakayama H.
    J Alzheimers Dis; 2014 Aug 30; 42(2):587-605. PubMed ID: 24916544
    [Abstract] [Full Text] [Related]

  • 8. Exosomes Isolated From Human Umbilical Cord Mesenchymal Stem Cells Alleviate Neuroinflammation and Reduce Amyloid-Beta Deposition by Modulating Microglial Activation in Alzheimer's Disease.
    Ding M, Shen Y, Wang P, Xie Z, Xu S, Zhu Z, Wang Y, Lyu Y, Wang D, Xu L, Bi J, Yang H.
    Neurochem Res; 2018 Nov 30; 43(11):2165-2177. PubMed ID: 30259257
    [Abstract] [Full Text] [Related]

  • 9. Soluble CCL5 derived from bone marrow-derived mesenchymal stem cells and activated by amyloid β ameliorates Alzheimer's disease in mice by recruiting bone marrow-induced microglia immune responses.
    Lee JK, Schuchman EH, Jin HK, Bae JS.
    Stem Cells; 2012 Jul 30; 30(7):1544-55. PubMed ID: 22570192
    [Abstract] [Full Text] [Related]

  • 10. Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models.
    Sebastian Monasor L, Müller SA, Colombo AV, Tanrioever G, König J, Roth S, Liesz A, Berghofer A, Piechotta A, Prestel M, Saito T, Saido TC, Herms J, Willem M, Haass C, Lichtenthaler SF, Tahirovic S.
    Elife; 2020 Jun 08; 9():. PubMed ID: 32510331
    [Abstract] [Full Text] [Related]

  • 11. Protection against RAGE-mediated neuronal cell death by sRAGE-secreting human mesenchymal stem cells in 5xFAD transgenic mouse model.
    Son M, Oh S, Park H, Ahn H, Choi J, Kim H, Lee HS, Lee S, Park HJ, Kim SU, Lee B, Byun K.
    Brain Behav Immun; 2017 Nov 08; 66():347-358. PubMed ID: 28760504
    [Abstract] [Full Text] [Related]

  • 12. Brain-derived neurotrophic factor modified human umbilical cord mesenchymal stem cells-derived cholinergic-like neurons improve spatial learning and memory ability in Alzheimer's disease rats.
    Hu W, Feng Z, Xu J, Jiang Z, Feng M.
    Brain Res; 2019 May 01; 1710():61-73. PubMed ID: 30586546
    [Abstract] [Full Text] [Related]

  • 13. Human umbilical cord blood-derived mesenchymal stem cells improve neuropathology and cognitive impairment in an Alzheimer's disease mouse model through modulation of neuroinflammation.
    Lee HJ, Lee JK, Lee H, Carter JE, Chang JW, Oh W, Yang YS, Suh JG, Lee BH, Jin HK, Bae JS.
    Neurobiol Aging; 2012 Mar 01; 33(3):588-602. PubMed ID: 20471717
    [Abstract] [Full Text] [Related]

  • 14. Long-term immunomodulatory effect of amniotic stem cells in an Alzheimer's disease model.
    Kim KS, Kim HS, Park JM, Kim HW, Park MK, Lee HS, Lim DS, Lee TH, Chopp M, Moon J.
    Neurobiol Aging; 2013 Oct 01; 34(10):2408-20. PubMed ID: 23623603
    [Abstract] [Full Text] [Related]

  • 15. Microglia contributes to plaque growth by cell death due to uptake of amyloid β in the brain of Alzheimer's disease mouse model.
    Baik SH, Kang S, Son SM, Mook-Jung I.
    Glia; 2016 Dec 01; 64(12):2274-2290. PubMed ID: 27658617
    [Abstract] [Full Text] [Related]

  • 16. Relationship between ubiquilin-1 and BACE1 in human Alzheimer's disease and APdE9 transgenic mouse brain and cell-based models.
    Natunen T, Takalo M, Kemppainen S, Leskelä S, Marttinen M, Kurkinen KMA, Pursiheimo JP, Sarajärvi T, Viswanathan J, Gabbouj S, Solje E, Tahvanainen E, Pirttimäki T, Kurki M, Paananen J, Rauramaa T, Miettinen P, Mäkinen P, Leinonen V, Soininen H, Airenne K, Tanzi RE, Tanila H, Haapasalo A, Hiltunen M.
    Neurobiol Dis; 2016 Jan 01; 85():187-205. PubMed ID: 26563932
    [Abstract] [Full Text] [Related]

  • 17. Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo.
    Farris W, Mansourian S, Chang Y, Lindsley L, Eckman EA, Frosch MP, Eckman CB, Tanzi RE, Selkoe DJ, Guenette S.
    Proc Natl Acad Sci U S A; 2003 Apr 01; 100(7):4162-7. PubMed ID: 12634421
    [Abstract] [Full Text] [Related]

  • 18. Reduced amyloid-β degradation in early Alzheimer's disease but not in the APPswePS1dE9 and 3xTg-AD mouse models.
    Stargardt A, Gillis J, Kamphuis W, Wiemhoefer A, Kooijman L, Raspe M, Benckhuijsen W, Drijfhout JW, Hol EM, Reits E.
    Aging Cell; 2013 Jun 01; 12(3):499-507. PubMed ID: 23534431
    [Abstract] [Full Text] [Related]

  • 19. Microglial dysfunction and defective beta-amyloid clearance pathways in aging Alzheimer's disease mice.
    Hickman SE, Allison EK, El Khoury J.
    J Neurosci; 2008 Aug 13; 28(33):8354-60. PubMed ID: 18701698
    [Abstract] [Full Text] [Related]

  • 20. The anti-inflammatory Annexin A1 induces the clearance and degradation of the amyloid-β peptide.
    Ries M, Loiola R, Shah UN, Gentleman SM, Solito E, Sastre M.
    J Neuroinflammation; 2016 Sep 02; 13(1):234. PubMed ID: 27590054
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.